-- CVS, Juniper, Progenics, PulteGroup, Sprint: U.S. Equity Movers
-- B y   N i k o l a j   G a m m e l t o f t
-- 2011-12-20T21:26:36Z
-- http://www.bloomberg.com/news/2011-12-19/at-t-red-hat-sprint-nextel-watson-u-s-equity-preview.html
Shares of the following companies
had unusual moves in U.S. trading. Stock symbols are in
parentheses, the prices are as of 4 p.m. in New York.  Financial companies advanced amid expectations the U.S.
economy will avoid a recession as a report showed builders broke
ground in November on the most houses since April 2010.  Bank of
America Corp. (BAC)   rose 3.7 percent to $5.17.  Citigroup Inc. (C) 
 gained 4.6 percent to $25.95.  JPMorgan Chase & Co. (JPM)   rose 4.9 percent to $32.22, the second-biggest gain in the
 Dow Jones Industrial Average .  Morgan Stanley (MS)   advanced
4.5 percent to $14.80.  Homebuilders also rose.  D.R. Horton Inc. (DHI)   increased
5.7 percent to $12.43.  Ryland Group Inc. (RYL)   rose 7.8
percent to $15.30.  PulteGroup Inc. (PHM)   rallied 10 percent
to $6.17, the biggest gain in the Standard & Poor’s 500 Index.  AT&T Inc. (T)   advanced 1.3 percent, the most since Nov.
30, to $29.12. The second-largest U.S. wireless operator
abandoned a $39 billion takeover bid for T-Mobile USA after
underestimating opposition from regulators, thwarting its
ambitions to become the biggest U.S. wireless carrier, ahead of
Verizon Wireless.  Sprint Nextel Corp. (S)  , the third-largest U.S. wireless
operator, rose 9.3 percent to $2.36.  Juniper Networks Inc. (JNPR)  , a maker of networking equipment, surged 8.9 percent to
$19.74.  Cisco Systems Inc. (CSCO)  , the world’s biggest maker
of networking equipment, jumped 4 percent to $18.41.  Cameron International Corp. (CAM)   gained 7.9 percent,
the most since Nov. 30, to $49.13. The maker of oilfield
equipment approved a stock buyback plan of up to $500 million.  Cobalt International Energy Inc. (CIE)   rose 37 percent
to $13.85, the biggest gain in the Russell 1000 Index. The deep-
water oil explorer, whose biggest investors include  Goldman
Sachs Group Inc. (GS)  , said oil was struck at an exploration
well off the coast of Angola.  ConAgra Foods Inc. (CAG)   gained 4.1 percent, the most
since December 2009, to $26.19. The maker of Hebrew National hot
dogs and Orville Redenbacher’s popcorn reported second-quarter
earnings excluding some items of 47 cents a share, compared with
the average estimate of 43 cents a share.  CVS Caremark Corp. (CVS)   rose 8.9 percent to $39.80, the
highest price since July 2008. The largest U.S. distributor of
prescription drugs boosted its quarterly dividend to 16.25 cents
a share from 12.5 cents a share.  F5 Networks Inc. (FFIV)   rose 6.7 percent, the most since
Nov. 30, to $109.39. The software maker was raised to
“outperform” from “market perform” at Oppenheimer & Co. by
Ittai Kidron, technology analyst. The 18-month price estimate is
$125 a share.  Jefferies Group Inc. (JEF)   rose 23 percent, the most
since November 2008, to $14.50. The investment bank that’s been
battling speculation about its financial strength reported
fourth-quarter profit that beat analysts’ estimates on a
recovery in fixed-income trading.  Navistar International Corp. (NAV)   rose 6.5 percent to
$38.91 for its biggest gain since Nov. 30. The maker of
International brand trucks posted adjusted fourth-quarter profit
of $3.37 a share, beating analysts’ estimate of $3.09 a share on
improved truck results.  Prestige Brands Holdings Inc. (PBH)   rose 20 percent, the
most since April 2009, to $11.20. The maker of Comet cleaner and
Murine eye and ear solutions agreed to buy 17 over-the-counter
medicine brands from  GlaxoSmithKline Plc (GSK)   for $660
million.  Progenics Pharmaceuticals Inc. (PGNX)   surged 31 percent
to $8.49, the biggest gain in the  Russell 2000 . The developer of
an injected constipation treatment said an oral version of the
drug helped patients in a late-stage trial.  Salix Pharmaceuticals Ltd. (SLXP)  , which licenses the
medication, climbed 8.6 percent to $46.94.  Red Hat Inc. (RHT)   fell 8.9 percent to $41.95, the
biggest decline in the  S&P 500 . The software maker that
specializes in the Linux operating system and other open-source
programs reported fiscal third-quarter billings and deferred
revenue that missed some analysts’ predictions.  Targacept Inc. (TRGT)   fell 36 percent, the biggest
decline in the Russell 2000 Index, to $4.99. The developer of an
experimental depression treatment with  AstraZeneca Plc (AZN)  
said the drug failed to meet the main goal of a second trial.  Zimmer Holdings Inc. (ZMH)   rose 6.3 percent, the most
since Jan 27, to $50.70. The world’s biggest maker of artificial
hip and knee joints rose after closely held rival Biomet Inc.
said sales of artificial hips climbed 7 percent in the quarter
ended Nov. 30, while demand for knees rose 2 percent. The
increase was greater than in the previous three months,
suggesting a market may be improving, said Derrick Sung, an
analyst with Sanford C. Bernstein & Co. in New York.  To contact the reporter on this story:
Nikolaj Gammeltoft in New York at 
 ngammeltoft@bloomberg.net   To contact the editor responsible for this story:
Nick Baker at 
 nbaker7@bloomberg.net  